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Abstract: Gout is the most prevalent form of arthritis that arises due to hyperuricemia. Xanthine oxidase inhibitors (XOI) are usually
prescribed to treat gout. Although treatment options are available, these therapies are associated with side effects, and natural remedies
may be proven helpful in this regard. This systematic review aims to present consolidated information on the xanthine oxidase inhibition
potential of the plants located in Pakistan. An extensive literature review reveals that no such study that systematically summarizes
existing data is currently available. The present study is registered with PROSPERO (ID: CRD42021247416) and performed according
to PRISMA guidelines. Several databases were searched (from January 2000 to April 2021) for the keywords, including “hyperuricemia”,
“xanthine oxidase inhibitory activity”, “medicinal plants”, “gout”, “Pakistan”, “in vivo”, and “in vitro”. The SYRCLE’s RoB tool was used to
assess the risk of bias. Total 22 articles met the inclusion criteria. Following plants had higher XO inhibitory activity (>75%); Bryophyllum
pinnatum, Zingiber officinale, Laggera aurita, Trachyspermum ammi, Tribulus terrestris, Trianthema triquetra, and Croton sparsiflorus.
Numerous phytochemicals were also identified, and the followings had potent activity; acacetin 1 (11.92 ± 0.01 µM), ranuncoside
(IC50 = 11.69 µM), chrysin 2 (IC50= 73.74 ± 0.02 µM), methyl-3,4,5-trihydroxybenzoate (IC50= 59.5 µM), costinone A (IC50= 90.3
± 0.06 µM), and umbelliferone (IC50= 97.12 ± 0.01 µM). This study will provide beneficial insight into medicinal plants and serve as
a reference for future studies on gout treatment. A rigorous pharmacological and clinical evaluation of medicinal plants is required to
gauge their efficacy and safety.
Key words: Gout, uric acid, xanthine oxidase, medicinal plants, arthritis, hyperuricemia

1. Introduction
Gout is a metabolic disorder and the most prevalent form
of arthritis caused by hyperuricemia. First, in 2640BC,
Egyptians documented this disorder. The word “gout”
originates from the Latin term “gutta” meaning drop.
Gout is also renowned as the “disease of kings”, as it is
more likely to be connected with lifestyle (Ashiq et al.,
2021). It is associated with various co-morbidities such
as hypertension, diabetes, stroke, obesity, chronic kidney
disease (CKD), and cardiovascular disorders (CVDs)
(Bardin T and Richette, 2017). Worldwide, the frequency of
this disease is quite uneven and affects developed countries
more than developing countries (Kuo et al., 2015). It is also
known as “men’s disease” as affecting men four times than
women. The lower incidence in women may be due to the
shielding effect of estradiol against the synthesis of urate
crystal. However, after menopause, females are also at a
higher risk of developing gout due to the loss of protective
effect induced by estrogen (Kanwal et al., 2018).

Gout is caused by increased serum uric acid levels
(>6.8mg/dL). Uric acid is mainly derived from the
catabolism of purine bases. In a first step, hypoxanthine
forms due to the breakdown of these nitrogenous bases,
and it is then converted into xanthine. Uric acid is
produced from xanthine by the action of the xanthine
oxidase enzyme (El Ridi and Tallima, 2017). Sustained
high serum uric acid levels ultimately lead to the formation
of monosodium urate crystals (MSU). MSU crystals start
to deposit in and around the joints where these crystals
provoke cell necrosis and inflammation. Acute gout usually
presents with symptoms of fever, deep pain, and marked
inflammation of joints. The term “podagra” describes the
condition when the first metatarsal joints are affected by
urate crystals deposition during an acute attack of the
disease. An acute stage lasts about 5 to 10 days followed by
an asymptomatic period of hyperuricemia. Chronic gout
persists for a longer time and presents with the formation
of tophi. As the disease progresses, multiple tophi can be
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found in any region of the body like bones, cutaneous
tissues, and joint spaces. If these tophi are left untreated,
permanent disability can be resulted (Hainer et al., 2014).
Over the last ten years, the mortality and morbidity
rate of gout has increased significantly, and the disease put
more economic burden on the healthcare system. Joint
pain, inflammation, restricted mobility, and treatment
expenses negatively influence the patient’s quality of life
(QoL). Lack of awareness, suboptimal treatment, shortage
of diagnostic facilities, and lifestyle of the patients are
the key challenges that are needed to address to prevent
or manage this disorder (Khanna et al., 2017; Ashiq
et al., 2017). Currently, many treatment options are
available such as NSAIDs (ibuprofen, naproxen, aspirin,
and indomethacin), corticosteroids, uricosuric agents
(probenecid and colchicine), cyclooxygenase 2 inhibitors
(etoricoxib), and xanthine oxidase inhibitors (allopurinol,
febuxostat and oxypurinol). However, side effects linked
with existing therapies may limit their use in clinical
practice, hence more future research is required to identify
an effective treatment with minimum side effects and cut
down the therapeutic expenses (Soskind et al., 2017; Abu
Bakar et al., 2018; Bredemeier et al., 2018).
The use of medicinal plants is rising considerably to
develop new pharmaceuticals that will have optimum
pharmacological activity with minimum or no side
effects. The biological activities of medicinal plants rely
on the presence of valuable phytochemicals, for example,
flavonoids, tannins, saponins, and alkaloids, etc. (Latif et
al., 2019). Pakistan has a wide range of treasured plant flora
due to its diverse topographic and climatic conditions. To
date, almost 6000 vascular plants have been identified that
play an imperative role in the socio-economy of Pakistan.
Despite this fact, only a little scientific work has reported
on their medicinal aspects, hence it demands more future
research. Currently, very little literature is available that
summarizes medicinal plants of the region and their
potential role in therapeutics (Islam et al., 2021).
1.1. Rationale
Through an extensive literature survey, we have not found
a single study that attempts to precisely recapitulate earlier
studies conducted on Pakistani medicinal plants and their
potential role in xanthine oxidase inhibition to treat gout.
1.2. Objective
The objective of this review is to assess systematically all
published articles on medicinal plants located in Pakistan
and their potential anti-gout effect. We hope that the
present study will provide a considerable evidence-based
comprehension of drug discovery and development
methods, and it will prove as a reference for coming
studies.
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2. Methodology
2.1. Study reporting and registration
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA, 2009) statement has been
followed for this study (supplementary file no: 1).
This systematic review is registered with PROSPERO,
NIHR (International Prospective Register of Systematic
Reviews, National Institute for Health Research, United
Kingdom). The registration number is CRD42021247416
(supplementary file no. 2).
2.2. Search strategy
Google Scholar, PubMed, Scopus, ScienceDirect,
MEDLINE and Cochrane Library were searched for
the keywords, including medicinal plants, Pakistan,
hyperuricemia, xanthine oxidase inhibition, gout, in vivo,
and in vitro. The articles published from January 2000 to
April 2021 are included in this study.
2.3. Inclusion and exclusion criteria
In vitro and in vivo studies conducted on medicinal plants
of Pakistan were considered for this systematic review.
Studies that identified active compounds were used for
this study as well. Articles published only in the English
language were included in this study.
Narrative reviews, comments, systematic reviews,
books, meta-analyses, duplicate articles, posters, case
reports, doctoral thesis, and presentations were excluded
from the current study.
2.4. Data extraction and statistical analysis
Six independent investigators were involved in extracting
and examining the data. For this review, the data were
collected according to a pre-designed form. The following
information was included in the form: the plant name,
family, part used, solvent for extraction, data on the
bioassay/model used, inhibitory concentration (IC50),
phytochemicals present in the extracts, major outcomes,
author name, and year of publication. The data were entered
and saved in an Excel sheet, checked for any duplication,
and removed. Microsoft Office Excel Worksheet (2010)
was used for constructing graphs. Due to methodological
heterogeneity, meta-analysis was not performed.
2.5. Quality assessment of studies
A careful review of the retrieved reports was done
independently by five researchers. The assessments
included were as follows: carrying out a literature search,
sequentially screening their titles, evaluating abstracts, and
examining relevant studies. In case of any discrepancy, the
sixth researcher was consulted to resolve a disagreement.
For the experimental design of in vivo studies, the risk of
bias was tested by using SYRCLE’s RoB tool for animal
studies (Hooijmans et al., 2014).
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Screening

Identification

3. Results and discussion
3.1. Selection of the literature and study characteristics
A total of 338 records were identified based on the search
strategy. We found 22 articles eligible for the current study
based on inclusion criteria. Eleven articles including
studies performed on synthetic compounds (n=6), in
silico studies (n=2), and the plant material imported from
other countries (n=3) were disqualified based on specific
reasons. The literature selection process is illustrated in
Figure 1.
The characteristics of the included studies are
described in Table 1, encompassing the author’s name,
year of publication, study area, and the plant used. Also,
the number of papers published per year was computed,
and the results are displayed in Figure 2. The present study

Records identified from
Databases
(n = 338)

Eligibility

Additional records identified
through other sources
(n = 0)

Records after duplicates removed
(n = 183)

Records screened
(n = 34)

Included

results have revealed that for the first time in 2006, research
was published on Pakistani medicinal plants to test their
potential inhibitory effect on xanthine oxidase. Before the
year 2006, not a single scientific work was discovered by an
exhaustive literature survey. Among 22 studies, only two
studies have documented in vivo activity of the medicinal
plants against gout. The first in vivo study was reported in
2008, followed by the second investigation documented in
2019.
3.2. In vitro studies
The xanthine oxidase inhibition activity has been assessed
in 22 medicinal plants located in Pakistan. The present
study outcomes have shown that plants selected for
investigation belong to a diverse range of 22 families.
Merely in four families named Apiaceae, Leguminosae,

Full-text articles assessed for
eligibility
(n = 34)

Records excluded
(n =149)

Full-text articles excluded,
with reasons (n = 11)
Full-text articles not available
(n = 1)

Studies included in review
(n = 22)

Figure 1. Flow diagram of study selection.
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Figure 1. Flow diagram of study selection
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Table 1. Study characteristics.
Reference

Area of the plant collection in Pakistan

Plant name

Ahmad et al., 2008

Murree Hills

Pistacia integerrima

Ahmad et al., 2010

Kala Shah Kaku, Muridke

Croton sparsiflorus

Ahmad et al., 2010

North-West Frontier Province (N.W.F.P.) Swat

Isatis costata

Ahmad et al., 2017

Pattoki, District Kasur, Punjab

Lagenaria siceraria

Ahmad et al., 2019

Rawalpindi

Cassia absus

Ahmad et al., 2020

Karachi

Apium graveolens, Colchicum autumnale, Berberis
vulgeris, Trachyspermum ammi

Akram et al., 2014

Karachi

Apium graveolens, Colchicum autumnale, Tribulus
terrestris, Withania somnifera, Zingiber officinale

Alam et al., 2021

Tandyani (Hazara) KPK

Viburnum grandiflorum

Arshad et al., 2020

Cholistan Desert near Bahawalpur, Punjab,

Indigofera argentea

Bilal et al., 2019

Bahawalpur

Trachyspermum ammi

Gul et al., 2021

Karak, KPK

Ricinus communis

Karim et al., 2009

Karachi

Barleria acanthoides

Khan et al., 2006

Karachi

Amberboa ramose

Khan et al., 2008

Nathia Gali, Hazara Hills, N.W.F.P.

Ranunculus repens

Khurshid et al., 2019

Cholistan desert, district Bahawalpur

Trianthema triquetra

Latif et al., 2020

Botanical garden of University of the Punjab, Lahore Bryophyllum pinnatum

Rauf et al., 2016

Gilgit

Potentilla evestita

Raziq et al., 2017

Peshawar

Ranunculus muricatus

Saeed and Ahmed, 2015

Collected from the hills near Abbottabad

Carissa opaca

Saeed and Shahwar, 2015 Lahore

Syzygium aromaticum

Shaheen et al., 2020

Multan

Mimosa himalayana

Shahwar et al.,2012

Lahore

Laggera aurita

Euphorbiaceae, and Ranunculaceae, a maximum of two
species have been investigated. In the remaining families,
only one plant species was chosen for the evaluation of
xanthine oxidase activity. The data on the plant parts used
in all studies is exhibited in Figure 3. The plant parts are
used as whole plants (39%), roots (18%), seeds (11%), and
leaves (7%). Fresh flowering shoots, aerial parts, tubers,
bark, mesocarp of fresh fruit, and stem each constituted
4% individually. Pakistan has a rich diversity of botanical
flora and a vast hub of many important medicinal plants,
and, according to estimation, about 700 out of 6000 plant
species have therapeutic value. Pakistani population
greatly depends on medicinal plants for the treatment of
various ailments. However, in Pakistan, the exploration of
plants for medicinal purposes is still ignored. To date, only
twenty-two plant species were evaluated for their potential
anti-gout effect, and most of these researches were
conducted in vitro. More concentration on exploratory
studies of medicinal plants is desired in the future to
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address scientific gaps and for novel drug discovery and
development (Jan et al., 2019).
The in vitro studies data encompassing author’s name,
year, plant name, family, extraction, xanthine oxidase
inhibition (XOI) method followed, XOI %, IC 50 (ug/mL),
phytochemicals, and outcomes of the assay are summarized
in Table 2. The XOI% data was not available for the
following plants: Amberboa ramose, Barleria acanthoides,
Isatis costata, Pistacia integerrima, Ranunculus repens,
Ranunculus muricatus, Viburnum grandiflorum, and
Potentilla evestita (Khan et al., 2006; Ahmad et al., 2008;
Karim et al., 2009; Ahmad et al., 2010; Rauf et al., 2016;
Raziq et al., 2017; Alam et al., 2021). IC50 information was
not recorded for these plants Lagenaria siceraria, Cassia
absus, Indigofera argentea, and Bryophyllum pinnatum
(Ahmed et al., 2017; Ahmad et al., 2019; Arshad et al.,
2020; Latif et al., 2020). In seven medicinal plant species
included, Amberboa ramose, Barleria acanthoides,
Isatis costata, Potentilla evestita, Ranunculus muricatus,
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In vitro
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2020

2019

2018

1

2017
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1
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1
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2012

1

2

2021

2

2011

1

2010

1

2009

2005

2004

2003

2002

2001

2000

2007

1

1

2008

2

2

0

In vivo

3

3

2006

No. of studies published

8

Years

Figure 2. Number of papers published per year.
Mesocarp of young
fresh fruit (Lagenaria
siceraria)
4%

Figure 2. Number
of papersshoots
published per year
Fresh flowering

(Mimosa himalayana)
4%
Aerial parts (Laggera
Tuber
aurita)
(Colchicum
4%
Leaves (Pistacia autumnale)
4%
integerrima,
Ricinus
communis)
7%

Roots (Bryophyllum
pinnatum, Carissa
opaca, Ranunculus
repens, Ricinus
communis, Viburnum
grandiflorum)
18%
Fresh buds (Syzygium
aromaticum)
3%

Stem (Viburnum
grandiflorum)
3%

Stem Bark (Berberis
vulgeris)
3%

Whole plants
(Amberboa ramosa,
Barleria acanthoides,
Croton sparsiflorus,
Indigofera argentea,
Isatis costata, Potentilla
evestita, Ranunculus
muricatus, Trianthema
triquetra, Tribulus
terrestris, Withania
somnifera, Zingiber
officinale)
39%

Seeds (Apium
graveolens, Cassia
absus, Trachyspermum
ammi)
11%

Figure 3. Parts of medicinal plants used in different studies.

Ranunculus repens, and Syzygium aromaticum, several
phytochemicals were isolated and elucidated for potential
XOI activity (Khan et al., 2008; Karim et al., 2009; Ahmad

et al., 2010; Saeed and Shahwar, 2015; Rauf et al., 2016;
Raziq et al., 2017). IC50 is a concentration at which 50%
of the xanthine oxidase activity was inhibited. Khan et al.
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Table 2. In vitro studies investigated to evaluate medicinal plants inhibitory effect on xanthine oxidase.

Reference

Ahmad et al.,
2008

Ahmad et al.,
2010

Pistacia
integerrima

Croton
sparsiflorus

Isatis costata

Family

Common/local
name

Anacardiaceae

Villana, Thoak,
kakarsinghi,
habb-e-suranjan
(traditional
dosage form)

Euphorbiaceae

Brassicaseae

Ban Tulasi, Raan
Tulas

NA

Part used

Fresh leaves

Extraction

Aqueous extract and
solvent fractions

Extraction was done
in nine different
solvents in sequential
manner (n-hexane,
Whole plant dichloromethane,
chloroform, ethyl
acetate, acetone,
methanol, ethanol,
n-butanol and water)

Whole plant

Ethanolic extract and
solvent fractions

XOI (%)

IC50
(for the extracts and isolated
compounds units are µg/mL
and µM, respectively)

Active compound(s)

Outcomes of the assay

NA

Aqueous extract = 85
Ethanol:water (4:1) extract = 59
Ethanol:water (1:1) extract = 60
Chloroform extract = 44
Ethyl acetate extract = 20
n-butanol extract = 19

Flavonoids

Significant inhibitory
activity against the
enzyme xanthine oxidase

n-hexane extract = 7.1 ±
0.1 at 100 µg/mL
Dichloromethane extract
= 73.2 ± 0.3 at 100 µg/mL
Chloroform extract = 75.1
± 0.5 at 100 µg/mL
Ethyl acetate extract =
74.2 ± 0.2 at 100 µg/mL
Acetone extract = 70.4 ±
0.3 at 100 µg/mL
Methanolic extract = 45.3
± 0.8 at 100 µg/mL
Ethanolic extract = 61.1 ±
1.0 at 100 µg/mL
n-butanol extract = 55.8 ±
0.2 at 100 µg/mL
Water extract = 8.5 ± 0.5
at 100 µg/Ml

n-hexane extract = -Dichloromethane extract = 23.82
Chloroform extract = 17.34
Ethyl acetate extract = 9.31
Acetone extract = 11.35
Methanolic extract = -Ethanolic extract = 43.25
n-butanol extract = 87.51
Water extract = --

NA

Moderate to significant
inhibition of the xanthine
oxidase enzyme

NA

Compound 1
Costinone A = 90.3±0.06
Compound 2
Costinone B =: 101.7±0.02
Compound 3
Isatinone A = 117.5±0.03
Compound 4
Isatinone B = 130.6±0.05
Compound 5
Indirubin = 170.5±0.01
Compound 6
Trisindoline = 179.6±0.04

Compounds 1-6 showed
Costinone A, Costinone B,
a significant to moderate
Isatinone A, Isatinone B,
inhibition of the xanthine
Indirubin, Trisindoline
oxidase enzyme activity

ASHIQ et al. / Turk J Bot

Ahmad et al.,
2010

The plant
scientific
name

Table 2. (Continued).

Ahmad et al.,
2017

Ahmad et al.,
2020
Akram et al.,
2014
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Ahmad et al.,
2020

Cassia absus

Cucurbitaceae

Leguminosae

Ghia or Ghia
kaddu

Chaksu

NA

Significant activity
shown by n-butanol
extract while no activity
was reported in aqueous
extract

ASHIQ et al. / Turk J Bot

Ahmad et al.,
2019

Lagenaria
siceraria

Aqueous extract = 0 at
100 µg/mL
n-hexane =
20 at 100 µg/mL
Mesocarp of Methanolic
Methanol =
young fresh extract of the fruit and
34 at 100 µg/mL
fruit
its fractions
Ethyl acetate =
35 at 100 µg/mL
n-butanol =
52 at 100 µg/mL

Revealed the
presence of a
variety of chemical
compounds, including
4-(methoxymethyl)
phenol, 2,2ʹ-methylenebis,
phenol, methyl 2-hydroxy3-phenylpropanoate,
oxacyclododecane2,8-dione, N-(2-(4hydroxyphenyl)ethyl]
acetamide, 2,3Epoxycarane, 4-(propan2-yl) benzaldehyde,
octadec-1-ene,
4amethyl-1-methylidene1,2,3,4,4a,9,10,10aoctahydrophenanthrene,
2,6-di(propan-2-yl)
naphthalene, methyl
3-(4-hydroxy-3,5dimethylphenyl)
propanoate,
4,8a-dimethyl-6-(prop1-en-2-yl)-3,5,6,7,8,8a
hexahydronaphthalen2(1H)-one 1,3-dihydro-2benzofuran, methyl
N-hydroxybenzene
carboximidoate, linoleic
acid, and palmitic acid

Seeds

Ethanolic extract and
its fractions

Ethanolic extract =
10.1±0.02 at
5 mg/mL
n-butanol = 29.2±0.02 at
5 mg/mL
Chloroform = 26.8±0.03
at
5 mg/mL
n-hexane = 35.5±0.02 at
5 mg/mL
Aqueous = 23.7±0.04 at
5 mg/mL

NA

NA

54 at 100 µg/mL

Ethanolic extract = 180

Phenolic compounds,
Flavonoids

Concentrationdependent XO inhibitory
effect

52 at 100 µg/mL

Ethanolic extract = 121

Phenolic compounds,
Flavonoids

Concentrationdependent XO inhibitory
effect

Apium
graveolens

Apiaceae

Tukhm-e-karafs

Seeds

Ethanolic extract
prepared by soaking
plant powder in
solvent

Berberis
vulgeris

Berberidaceae

Barbbery

Stem bark

Ethanolic extract
prepared by soaking
plant powder in
solvent

Weak to moderate
inhibition of xanthine
oxidase
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Table 2. (Continued).
Ahmad et al.,
2020
Akram et al.,
2014

Colchicum
autumnale

Ahmad et al.,
2020

Trachyspermum
Apiaceae
ammi

Ajwain

Akram et al.,
2014

Tribulus
terrestris

Zygophyllaceae

Gokshur or
Gokharu

Akram et al.,
2014

Withania
somnifera

Solanaceae

Ashwagandha,
Indian ginseng

Akram et al.,
2014

Zingiber
officinale

Zingiberaceae

Adrak, Ginger

Arshad et al.,
2020

Viburnum
Caprifoliaceae
grandiflorum

Indigofera
argentea

Fabaceae

Suranjan shirin

Guch

Neel, Jantari,
Hathio

Ethanolic extract
prepared by soaking
plant powder in
solvent
Ethanolic extract
prepared by soaking
Seeds
plant powder in
solvent
Ethanolic extract
prepared by soaking
Whole plant
plant powder in
solvent
Ethanolic extract
prepared by soaking
Whole plant
plant powder in
solvent
Ethanolic extract
prepared by soaking
Whole plant
plant powder in
solvent
Tuber

Stem and
roots

61 at 100 µg/mL

Ethanolic extract = 42

Phenolic compounds,
Flavonoids

Concentrationdependent XO inhibitory
effect

78 at 100 µg/mL

Ethanolic extract = 19.8

Phenolic compounds,
Flavonoids

Concentrationdependent XO inhibitory
effect

78 at 100 µg/mL

Ethanolic extract = 19.8

NA

Concentrationdependent XO inhibitory
effect

69 at 100 µg/mL

Ethanolic extract = 95

NA

Concentrationdependent XO inhibitory
effect

80 at 100 µg/mL

Ethanolic extract = 23.6

NA

Significant inhibitory
activity against the
enzyme xanthine oxidase

Compound 1
Benzofuran = 49.52 + 0.03

2, 3-dihydro-2-(4ʹ-hydroxy,
3ʹ-methoxyphenyl)Significant concentration
3-hydroxymethyldependent inhibition of
5-(2-formylvinyl)
the enzyme
7-hydroxybenzofuran
(benzofuran)

Ethanol extract and
its chloroform soluble NA
fraction

Methanol, n-hexane,
chloroform, and
Whole plant
n-butanol extracts/
fractions

n-hexane extract = 47.3 ±
0.5 at 5 mg/mL
Chloroform extract = 50
± 0.7 at 5 mg/mL
NA
n-butanol extract = 52.5 ±
0.9 at 5 mg/mL
Methanolic extract = 67.8
5 ± 0.4 at 5 mg/mL

Flavonoids, Lithocholic
acid, terpenes

Moderate to significant
inhibition of the xanthine
oxidase enzyme

72±0.5 at 0.5 mg/mL

Phenolic compounds,
Flavonoids

Significant inhibitory
activity against the
enzyme xanthine oxidase

Bilal et al.,
2019

Ethanolic extract
prepared by
maceration method

Gul et al.,
2021

Root silver nanoparticles extract =
3.60 ± 0.04
NA
Leaves silver nanoparticles extract
= 3.8 ± 0.03

Significant inhibitory
activity against the
enzyme xanthine oxidase

Compound 1
Barlerisides A = 419.0±3.167
Compound 2
Barlerisides B = 426.7±1.87

Comparable but weak
inhibitory activity against
the enzyme xanthine
oxidase

Karim et al.,
2009

Ricinus
communis

Euphorbiaceae

Castor Bean

Roots and
leaves

Root extract = 23 at 100
µg/mL
Leaves extract = 24 at 100
µg/mL
Methanolic extract
Root silver nanoparticles
and its green synthesis
extract = 83.6 at 100
of sliver nanoparticles
µg/mL
Leaves silver
nanoparticles extract = 83
at 100 µg/mL

Barleria
acanthoides

Acanthaceae

Thath

Whole plant

Methanolic extract
and solvent fractions

NA

Ethanolic extract = 68.6±0.2

Two new glycosides
called Barlerisides
A and B, acteoside,
p-hydroxycinnamic acid

ASHIQ et al. / Turk J Bot

Alam et al.,
2021

Colchicaceae

Table 2. (Continued).

Khan et al.,
2006

Khan et al.,
2008

Latif et al.,
2020

Ranunculus
repens

Trianthema
triquetra

Bryophyllum
pinnatum/
Kalanchoe
pinnata

Compositae

Ranunculaceae

Aizoaceae

Crassulaceae

Jafri

Buttercup

Red spinach,
Choti Ulwaiti

Pathar chat

Whole plant

Roots

Methanolic extract
and solvent fractions

Methanolic extract
and solvent fractions

Whole plant

Methanolic extract
and its fractions

Roots

Sequential extraction
was carried out
by using solvents;
n-hexane, chloroform,
methanol and water
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NA

New flavonol glycoside
reported; 5,7,4′-trihydroxy3,8-dimethoxylflavone
5-O-β-D-gluco-pyranoside,
6,4′-dihydroxy-3,5,7trimethoxyflavone,
5,7-dihydroxy-4′methoxyflavone,
(23R)-5α-cycloart-24-ene3β,21,23-triol

NA

Compound 1
R(+)-dalbergiphenol = 217.8
Compound 2
R(+)-4-methoxydalbergione =
359.2
Compound 3
methyl-3,4,5-trihydroxybenzoate
= 59.5

R(+)-dalberg phenol, R(+)Significant inhibitory
4-methoxydalbergione,
activity against the
methyl-3,4,5enzyme xanthine oxidase
trihydroxybenzoate

Methanolic extract = -n-hexane =
0.9±0.5
Ethyl acetate =
4.7±0.8
n-butanol = -Aqueous = --

9,12-octadecadienoic
acid (Z,Z)-, methyl ester,
hexadecanoic acid, methyl
ester, 9-octadecenoic
acid (Z)-, methyl ester,
9,12-octadecadienoic
acid, ethyl ester,
hexadecanoic acid,
ethyl ester, ethyl oleate,
1,2-benzenedicarboxylic
acid,
mono (2-ethylhexyl) ester,
vitamin E

Significant inhibitory
activity against the
enzyme xanthine oxidase

Polyphenols,
Flavonoids, Glycosaponin,
Polysaccharides

Significant inhibitory
activity against the
enzyme xanthine oxidase

Acacetin 1, Chrysin 2,
Umbelliferone 3

Significant inhibitory
activity against the
enzyme xanthine oxidase

Ranuncoside

Significant inhibitory
activity against the
enzyme xanthine oxidase

Methanolic extract =
26.32±0.9 at 5 mg/mL
n-hexane =
77.7±0.7 at 5 mg/mL
Ethyl acetate = 51.9±0.5 at
5 mg/mL
n-butanol = 19.1±0.4 at
5 mg/mL
Aqueous =
45.7±1 at 5 mg/mL

n-Hexane extract = 7.34 +
0.002 at 2mg/mL
Chloroform extract =
31.54 + 0.005 at 2mg/mL
NA
Methanolic extract =
88.30 + 0.004 at 2mg/mL
Water extract = 44.22 +
0.04 at 2mg/mL

Rauf et al.,
2016

Potentilla
evestita

Rosaceae

NA

Whole plant

Methanolic extract
and solvent fractions

NA

Compound 1
Acacetin 1 = 11.92±0.01
Compound 2
Chrysin 2 = 73.74±0.02
Compound 3
Umbelliferone 3 = 97.12±0.01

Raziq et al.,
2017

Ranunculus
muricatus

Ranunculaceae

Chambel,
Crowfoot,
Buttercup

Whole plant

Methanolic extract
and solvent fractions

NA

Compound 1
Ranuncoside = 43.3 ± 0.22

Moderate inhibition of
xanthine oxidase enzyme
by compound 2 and
compound 3
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Khurshid et
al., 2019

Amberboa
ramose

Compound 1
5,7,4′-trihydroxy-3,8dimethoxylflavone 5-O-β-D-glucopyranoside = 408.5
Compound 2 6,4′-dihydroxy-3,5,7trimethoxyflavone = 139.2
Compound 3 5,7-dihydroxy-4′methoxyflavone = 177.8
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Table 2. (Continued).

Saeed and
Ahmad 2015

Saeed and
Shahwar,
2015

Carissa opaca Apocynaceae

Syzygium
aromaticum

Myrtaceae

Leguminosae/
Mimosaceae

Shahwar et al., Laggera
2012
aurita

Asteraceae

Clove

NA

Methanolic extract
prepared by cold
maceration and its
fractions

Polyphenols, flavonoids,
Limonene, vanillin,
lupeol, rutin, quercetin,
β-sitosterol, Vitamin E,
2-hydroxyacetophenone,
Significant inhibitory
naphthalenone,
activity against the
2,3,3-trimethyl-2-(3enzyme xanthine oxidase
methylbuta-1,3-dienyl)-6methylenecyclohexanone,
and 2-benzenedicarboxylic
acid, mono(2-ethylhexyl)
ester.

Fresh buds

Extract prepared by
steam distillation
using Dean Stark
apparatus

Compound 1
Essential oil = 85.1±2.2 at
150 µg/mL
Compound 2
Eugenol = 81.2±3.0 at 150
µg/mL
Compound 3
Hyoscine = --

Compound 1
Essential oil = 61.9±2.1
Compound 2
Eugenol = 43.5±2.6
Compound 3
Hyoscine = --

Essential oil, Eugenol,
Hyoscine

Significant inhibitory
activity against the
enzyme xanthine oxidase

Fresh
flowering
shoots

Ethanolic extract
prepared by
maceration

66.1 at 100 µg/mL

Ethanolic extract = 83.5

NA

Significant inhibitory
activity against the
enzyme xanthine oxidase

Aerial parts

Extraction was done
by steam distillation
using Dean Stark
apparatus.

79.05 ± 7.39 at 100 µg/mL Extract = 45 ± 0.009

Fatty acids, sesquiterpene,
hydrocarbon,
Monoterpene, phenolic
derivatives

Significant inhibitory
activity against the
enzyme xanthine oxidase

Roots
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Shaheen et al., Mimosa
2020
himalayana

Granda

Methanolic extract = 45 at
100 µg/mL
Ethyl acetate = 43 at 100
Methanolic extract = 156
µg/mL
Ethyl acetate = 129
Chloroform =
Chloroform = 154.2
43 at 100 µg/mL
n-butanol =
18 at 100 µg/mL
n-hexane = --

IC50(ug/mL)
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Figure 4. IC50 comparison of the plants in various extracts.

(2006) investigated Amberboa ramosa
isolated
three
11.69
µM),plants
and Syzygium
aromaticum;
essential oil (IC50=
Figureand
4. IC50
comparison
of the
in various
extracts
flavonoids
(5,7,4′-trihydroxy-3,8-dimethoxylflavone
61.9 ± 2.1 µM) and eugenol (IC50= 43.5±2.6 µM) have
5-O-β-D-gluco-pyranoside
(IC50=
408.5
µM),
displayed a significant inhibitory action on the xanthine
5,7-dihydroxy-4′-methoxyflavone (IC50= 177.8 µM), and
oxidase enzyme. Until now, these phytochemicals were not
6,4′-dihydroxy-3,5,7-trimethoxyflavone (IC50= 139.2
further examined or developed into a formulation to treat
µM) that possessed weak to moderate xanthine oxidase
gout (Khan et al., 2008; Saeed and Shahwar, 2015; Raziq et
inhibitory activity (Khan et al., 2006). In proceeding
al., 2017; Rauf et al., 2018).
studies, the presence of many chemicals (cinnamic acid,
In fifteen plants, xanthine oxidase inhibition activity
stigmasterol, marrusidin A, and marrusidin B) has been
was measured in different extracts (Table 2, Figure 4).
confirmed in Amberboa ramose; however, limited data are
Ethanol was frequently used as a solvent for the extraction
available on its pharmacological activities (Ibrahim et al.,
followed by methanol and water. The selection of solvent
2012). Barleria acanthoides contains two potent phenolic
has a considerable influence on the isolation of chemical
glycosides called barlerisides A (IC50= 419.0 ± 3.167 µM)
compounds, pharmacological activity, and toxicity (Abu
and barlerisides B (IC50= 426.7 ± 1.87 µM), but they
Bakar et al., 2018). Apium graveolens, Berberis vulgeris,
possessed weak activity against xanthine (Karim et al.,
Colchicum autumnale, Trachyspermum ammi, Tribulus
2009). Six oxindole alkaloids (costinone A: IC50= 90.3 ±
terrestris, Withania somnifera, and Viburnum grandiflorum
0.06µM, costinone B: IC50= 101.7±0.02 µM, isatinone A:
exhibited concentration-dependent inhibition of xanthine
IC50= 117.5 ± 0.03 µM, isatinone B: IC50= 130.6 ± 0.05
oxidase. A significant activity against xanthine oxidase
µM, indirubin: IC50= 170.5 ± 0.01 µM, and trisindoline:
inhibition was also shown by Pistacia integerrima,
IC50= 179.6 ± 0.04 µM) were isolated from Isatis
Lagenaria siceraria, Ricinus communis, Trianthema
costata, and these entire chemicals showed moderate to
triquetra, Bryophyllum pinnatum, Carissa opaca, Mimosa
substantial xanthine oxidase inhibition activity (Ahmad
himalayana, and Laggera aurita. Croton sparsiflorus and
et al., 2010). The assessment of other plants revealed the
Indigofera argentea exhibited mild to significant activity,
occurrence of many valuable phytochemicals Potentilla
while Cassia absus had weak to moderate activity against
evestita; acacetin 1 (IC50= 11.92 ± 0.01 µM), chrysin 2
the xanthine oxidase.
(IC50= 73.74 ± 0.02 µM), and umbelliferone (IC50= 97.12
The maximum XOI% of plants according to the available
± 0.01 µM), Ranunculus repens; 3R(+)-dalbergiphenol
information is found as: Bryophyllum pinnatum 88.30%
(IC50= 217.8 µM), R(+)-4-methoxydalbergione (IC50=
(methanolic extract) at 2 mg/mL, Zingiber officinale 80%
359.2 µM), and methyl-3,4,5-trihydroxybenzoate (IC50=
(ethanolic extract) at 100 µg/mL, Laggera aurita 79.05%
59.5 µM), Ranunculus muricatus; ranuncoside (IC50=
(ethanolic extract) at 100 µg/mL, Trachyspermum ammi
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Table 3. In vivo studies investigated to evaluate medicinal plants inhibitory effect on xanthine oxidase.
Author
(Year)

Scientific
Name

Bilal et al.,
2019

Common/ local Part
name
used

Thoak,
kakarsinghi,
marketed in
a traditional
dosage form
Anacardiaceae ‘habb-esuranjan’ by
Hamdard
Laboratories
(WAQF)
Pakistan

Trachyspermum
ammi
Apiaceae

Ajwain

Fresh
leaves

Seeds

Extraction

Experimental
animal model

Uric acid
lowering effect in
Aqueous
fructose- induced
extract and hyperuricemic
solvent
mice model as
fractions
described by
Newman and
Price (1996)

Hyperuricemia
was induced in
Ethanolic
rats by
extract
administration
prepared by
of potassium
maceration
oxonate as
method
described by
Zaho et al., (2006)

Dose

Active
Toxicity
compound(s)

10 mg/kg to 160
mg/kg extract
dose given to
mice.
Blood samples
Flavonoids
were collected
after every 1 to 4
hours to measure
serum uric acid

250 mg/kg and
500
Mg/kg for 1,
3, and 7 day s,
respectively.

Phenolic
compounds,
Flavonoids

Outcomes of
the assay

Dosedependent
inhibitory
activity
ED 20 = 28 mg/kg
against
xanthine
oxidase
enzyme

No data on toxicity
was reported.
However, previous
dose fixation
studies showed
non-toxic nature
of T.ammi seeds
extract from the
dose range of 1 and
5 g/kg body weight
in normal rats.

Inhibit
xanthine
oxidase
enzyme
activity
in timedependent
manner
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Ahmad et al., Pistacia
2008
integerrima

Family

ASHIQ et al. / Turk J Bot
78% (ethanolic extract) at 100 µg/mL, Tribulus terrestris
78% (ethanolic extract) at 100 µg/mL, Trianthema
triquetra 77.7% (n-hexane extract) at 5 mg/mL, Croton
sparsiflorus 75.1% (chloroform extract) at 100 µg/mL,
Indigofera argentea 67.8% (methanolic extract) and 72%
(ethanolic extract) at 5 mg/mL, Withania somnifera 69%
(ethanolic extract) at 100 µg/mL, Indigofera argentea
67.8% (methanolic extract), Mimosa himalayana 66.1%
(ethanolic extract) at 100 µg/mL, Lagenaria siceraria 52%
(n-butanol extract) at 100 µg/mL, Apium graveolens 54%
(ethanolic extract) at 100 µg/mL, Berberis vulgeris 52%
(ethanolic extract) at 100 µg/mL, Colchicum autumnale
61% (ethanolic extract) at 100 µg/mL, and Cassia absus
29.2% (n-butanol extract) at 5 mg/mL. Gul et al., (2021)
conducted a study on Ricinus communis roots and its
leaves methanolic extract, and also prepared their silver
nanoparticles. This research suggested that XOI% of the
methanolic extract of silver nanoparticles (roots 83.6%
and leaves 83%) showed more effectiveness in comparison
to simple methanolic extract (roots 23%, and leaves 24%).
The phytochemical investigation was not performed
on Croton sparsiflorus, Zingiber officinale, Withania
somnifera, Tribulus terrestris, Ricinus communis, and
Mimosa himalayana hence there is a need for more indepth study. Other than these plants, the phytochemical
analysis demonstrated the presence of many important
compounds, i.e. flavonoids, polyphenols, alkaloids, and
glycosides. It is proven by previous studies that flavonoids,
alkaloids, glycosides, and phenolic compounds can inhibit
or lessen the production of uric acid. These constituents
tend to reduce inflammation by their uricosuric effect.
It is proposed that those plants that owned anti-oxidant
potential could be used as a potent inhibitor of the
xanthine oxidase. In light of the above-mentioned facts,
it is suggested that further research should be conducted
to spot the bioactive compounds of the medicinal plants
and to comprehend their mechanism of action so that the
wisdom behind their anti-gout effect can be justified. It will
also extend the usage of natural therapies with minimum
side effects and maximum efficacy, as there is hardly a
known natural remedy that is available to treat gout (Ling
and Bochu, 2014; Ojha et al., 2017). Medicinal plants
indigenous to Pakistan have shown a significant anti-gout
effect. These plants have important bioactive compounds
(i.e. polyphenols, flavonoids, tannins, steroids, etc.) that
can be used to treat gout particularly in alternative or
complementary medicines. The regional difference could
have an impact on the synthesis and activity of bioactive
compounds. The current information can be used to
correlate the findings of the local region to the other
regions of the world (El Dahiyat et al., 2020). For example,
a study conducted in Pakistan on Zingiber officinale has
shown similar xanthine oxidase inhibitory activity (80%) in

relation to the study conducted in Malaysia (81.56%) (Abu
Bakar et al., 2018). Apium graveolens seeds have exhibited
higher (54 at 100 µg/mL) xanthine oxidase activity in a
Pakistan study as compared to a study conducted in Czech
on aerial parts of the plant (1.4 at 200 µg/mL) (Havlik et
al., 2010).
3.3. In vivo studies
The results obtained from the in vitro studies provide
valuable knowledge and guidance for further screening in
animals. The data relating to in vivo studies are summarized
in Table 3. So far, in vivo studies were conducted only about
in two plants, named Pistacia integerrima (Ahmad et al.,
2008) and Trachyspermum ammi (Bilal et al., 2019). Both
plants exhibited significant in vitro activity as well. Ahmad
et al. (2008) used a fructose-induced hyperuricemia model.
Fructose solution in large doses amplifies the production
of AMP and ADP and causes the up-regulation of AMP
deaminase. The over-activity of xanthine oxidase (XO)
enzyme and substrate will boost the production of uric
acid and reactive oxygen species (ROS) (Nakagawa et al.,
2019). Pistacia integerrima fresh leaves were extracted in
an aqueous solvent, and its various fractions were made in
different solvents. Ethyl acetate fraction showed promising
results and had a dose-dependent (varying from 8% at 20
mg/kg to 57.52% 20 mg/kg) effect on serum uric acid level.
The study outcomes revealed that Pistacia integerrima
showed efficacy almost equal to that of quercetin (45.6% at
25 mg/kg) but less than allopurinol (77.4% at 10 mg/kg).
The phytochemical analysis demonstrated the presence of
flavonoids in the plant (Ahmad et al., 2008).
Trachyspermum ammi seeds were extracted in ethanol,
and the potassium oxonate hyperuricemia model was
applied to measure the anti-gout effect. Potassium oxonate
induces hyperuricemia by blocking uricase as this enzyme
is important for the excretion of uric acid. At the first
day of treatment, allopurinol considerably decreases
the serum uric acid level (2.8 mg/dL at a dose of 10 mg/
kg), while Trachyspermum ammi exhibited moderate
response (4.1 mg/dL at 250 mg/kg and 3.8 mg/dL at
500 mg/kg). At the seventh day, Trachyspermum ammi
demonstrated comparable response (2.5 mg/dL at 250
mg/kg and 2.1 mg/dL at 500 mg/kg) with allopurinol
(2.51 mg/dL at 10 mg/kg). It is evident from the findings
that Trachyspermum ammi displayed a time-dependent
response and also enhanced the renal excretion of uric
acid. The chemical analysis of the plant indicated that it
contains flavonoids and polyphenols. The toxicity studies
of the plant ware not performed (Bilal et al., 2019).
It is believed that the presence of flavonoids and
phenolic compounds in the plant makes them a
favorable choice to treat a triad of disorders like gouty
arthritis, ROS, and hyperuricemia due to their potential
antiinflammatory, antioxidant, and xanthine oxidase
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Ahmad et
al.,(2008)

+

+

Bilal et al.,
(2019)

+

+

+

-

-

+

Other bias

Selective outcome
(reporting bias)

Incomplete outcome data
(attrition bias)

Blinding evaluation
(performance bias)

Allocation cover up
(selection bias)

Random assignment
(selection bias)
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+

+

Where
+

= Lower risk of bias

-

= Higher risk of bias

= Unclear risk of bias

Figure 5. Categories of different risk of bias in two in vivo studies
Figure 5. Categories of different risk of bias in two in vivo studies

inhibitory effect (Tungmunnithum et al., 2019). Advance
research is recommended in order to evaluate medicinal
plants in terms of their potential efficacy, bioavailability,
and possible toxicity. Furthermore, the clinical assessment
of the formulations based on medicinal plants must be
performed (Abu Bakar et al., 2018).
3.4. Study methodological quality and risk of bias
The risk of bias (RoB) was checked according to SYRCLE’s
RoB tool to augment the transparency and applicability
of the animal studies. The results are illustrated in
Figure 5. The SYRCLE’s RoB tool is a tailored version
of the Cochrane RoB tool, which is implemented to
critically evaluate animal interventions. These papers
were characterized based on the following parameters:
random allocation of the animals, detailed procedure
of animal confinement, guidelines followed for animal
handling, blinding details, control and reference groups,
experimental design, and reporting of the data. Only
in one study, information on blinding evaluation and
estimation of the plant toxicity was not reported. The
animal studies lacking information on the randomization
and blinding process are considered less significant
scientifically while applying animal models (Hooijmans
et al., 2014; Gandhi et al., 2016).
3.5. Limitations
For the current review, articles only published in the
English language were considered. This review only
focused on medicinal plants that are available in Pakistan,
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and the results obtained from other regions of the world
must be summarized to have a comprehensive document.
The standardization of plant extract is essential to
validate therapeutic potency and safety. As many
extracts are used without standardization, care must be
taken when generalizing the findings. Only preliminary
phytochemical investigation of the plants was done
in animal studies therefore, exhaustive analysis is a
prerequisite to identify the chief component responsible
for pharmacological activity. In addition, toxicological
studies of the extracts must be performed so that possible
side effects will be elucidated before the clinical trials.
4. Conclusion
This systematic review assembled scattered data on
xanthine oxidase activity of medicinal plants which are
sited in Pakistan. Many isolated phytochemicals prove to
be beneficial in the reduction of hyperuricemia. So far,
little scientific work is found, and a majority of the studies
are conducted in vitro. Ethnic and cultural knowledge
may help in identifying medicinal plants that have desired
curative effects. More inclusive pharmacological and
clinical studies are warranted to ensure the safety, efficacy,
and toxicity of the medicinal plants, and their translational
use in human therapeutics.
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